Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gillet

Showing results (241-250 of 244) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 244 results.
Breast Cancer Research and Treatment|February 9, 2017
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyM Higgins, G Curigliano, V Dieras, et al.
Brain, Behavior, and Immunity|June 4, 2018
Early life stress in mice is a suitable model for Irritable Bowel Syndrome but does not predispose to colitis nor increase susceptibility to enteric infectionsA Riba, M Olier, S Lacroix-Lamandé, et al.
Nature Medicine|July 14, 1998
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapyS Fleury, R J de Boer, G P Rizzardi, et al.
ESMO Open|November 16, 2016
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation studyR Gutzmer, L Rivoltini, E Levchenko, et al.
Pageof 25

Showing results (241-250 of 244) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 244 results.
Breast Cancer Research and Treatment|February 9, 2017
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyM Higgins, G Curigliano, V Dieras, et al.
Brain, Behavior, and Immunity|June 4, 2018
Early life stress in mice is a suitable model for Irritable Bowel Syndrome but does not predispose to colitis nor increase susceptibility to enteric infectionsA Riba, M Olier, S Lacroix-Lamandé, et al.
Nature Medicine|July 14, 1998
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapyS Fleury, R J de Boer, G P Rizzardi, et al.
ESMO Open|November 16, 2016
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation studyR Gutzmer, L Rivoltini, E Levchenko, et al.
Pageof 25